1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 30792807 | Anticancer response to disulfiram may be enhanced by co-treatment with MEK inhibitor or oxaliplatin: modulation by tetrathiomolybdate, KRAS/BRAF mutations and c-MYC/p53 status. | 2019 | 1 |